Through his postdoctoral research, Firas is leveraging the expanding number of clinical genomic data to identify novel targets for immunotherapy and early cancer detection.
Firas obtained his PhD in Immunology and Computational Genomics at Cambridge University, where he investigated how enhancer-promoter interactions drive cell-fate decisions within the CD4+ T cell lineage to determine their immune response.
While in the U.S., he identified lineage-specific roles of key oncogenic proteins in childhood leukaemia at the University of California San Francisco (UCSF).
At the University Hospital of Düsseldorf (UKD), he worked on the tumorigenic potential of aberrant mesenchymal stem cells (MSCs) in relapsing childhood leukaemia.
As a postgraduate, he obtained an MSc in Immunology for his work on the binding ability of the viral RL11 protein family to the cells of the immune system at Hanover Medical School (MHH).
Prof. Serena Nik-Zainal
Early Cancer Institute
University of Cambridge
Hutchison Research Centre
Cambridge Biomedical Campus